Stay updated on Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial page.

Latest updates to the Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial page
- Check3 days agoChange DetectedAdded a new Revision: v3.3.3 and removed HHS Vulnerability Disclosure as well as Revision: v3.3.2 from the page history.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.3.2 was added to the history, and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding status notice banner on the page has been removed.SummaryDifference0.6%

- Check61 days agoChange DetectedA new version entry (Version 13, 2021-04-12) was added to the Record History, while the rest of the page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference12%

- Check90 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in HFpEF: Exercise Capacity Clinical Trial page.